Control release of mitochondria-targeted antioxidant by injectable self-assembling peptide hydrogel ameliorated persistent mitochondrial dysfunction and inflammation after acute kidney injury

Persistent mitochondrial injury occurs after acute kidney injury (AKI) and mitochondria-targeted antioxidant Mito-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) (MT) has shown benefits for AKI, but its efficiency is limited by short half-life and side effect in vivo. Self-assembling peptide (SAP) hydr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Deliv
Main Authors: Zhao, Meng, Zhou, Yijie, Liu, Shuyun, Li, Lan, Chen, Younan, Cheng, Jingqiu, Lu, Yanrong, Liu, Jingping
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058479/
https://ncbi.nlm.nih.gov/pubmed/29451033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1440445
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares